BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18 | -97.3% | 7,656 | -92.4% | 0.00% | – |
Q2 2023 | $671 | -35.8% | 100,720 | +79.8% | 0.00% | – |
Q1 2023 | $1,045 | +841.4% | 56,023 | +990.8% | 0.00% | – |
Q4 2022 | $111 | -98.9% | 5,136 | +533.3% | 0.00% | – |
Q3 2022 | $10,000 | -68.8% | 811 | -66.7% | 0.00% | – |
Q2 2022 | $32,000 | -47.5% | 2,437 | -15.6% | 0.00% | – |
Q1 2022 | $61,000 | -92.8% | 2,889 | -93.1% | 0.00% | – |
Q4 2021 | $852,000 | +171.3% | 41,858 | +304.8% | 0.00% | – |
Q3 2021 | $314,000 | +82.6% | 10,341 | +74.9% | 0.00% | – |
Q2 2021 | $172,000 | +681.8% | 5,912 | +1131.7% | 0.00% | – |
Q4 2020 | $22,000 | -98.2% | 480 | -98.3% | 0.00% | -100.0% |
Q3 2020 | $1,235,000 | +3759.4% | 28,487 | +4647.8% | 0.00% | – |
Q2 2020 | $32,000 | -68.3% | 600 | -91.4% | 0.00% | – |
Q4 2019 | $101,000 | +381.0% | 6,940 | +133.5% | 0.00% | – |
Q3 2019 | $21,000 | -51.2% | 2,972 | -23.5% | 0.00% | – |
Q2 2019 | $43,000 | -99.3% | 3,886 | -99.4% | 0.00% | -100.0% |
Q1 2018 | $6,331,000 | – | 618,249 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |